Sugar-Alcohol combo may restore periods in PCOS
NCT ID NCT07701525
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This phase 4 trial tests whether a daily combination of myo-inositol and D-chiro-inositol (with folic acid) can improve menstrual regularity and hormone levels in women with polycystic ovary syndrome (PCOS). Sixty women aged 18–45 with PCOS will receive either the inositol combination or a placebo (folic acid alone) for three months. Researchers will track changes in cycle length, bleeding, and blood levels of LH, FSH, and testosterone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a combination of myo-inositol and D-chiro-inositol (with folic acid)
- What this could lead to
- If effective, this combination could offer a simple, non-hormonal option to help regulate periods and improve hormone balance in women with PCOS.
- What could go wrong
- This is a small, short-term trial (60 women, 3 months), so results may not apply to all PCOS patients. The supplement may not outperform folic acid alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * diagnosed case of PCOS, ≥ 6-months Exclusion Criteria: * Hyperprolactinemia, hypothyroidism, adrenal hyperplasia or Cushing's syndrome (on history \& medical record review)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for D-chiro-inositol are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nishtar Medical University and Hospital Multan
Multan, Punjab Province, 60000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Patient's own blood plasma kickstart ovulation in PCOS?
- Could a pancreatic peptide hold clues to PCOS-Related insulin resistance?
- PCOS may fuel fatty liver in teens even after accounting for obesity — a study investigates
- Mind over menstrual pain: could a Four-Week online program ease PCOS symptoms?
- Could a diabetes drug boost pregnancy success in women with PCOS?
- Text messages as medicine: digital program aims to improve life with PCOS